• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article (55590786)   Find a Category (125)   Find a Journal (6168)   Find a Scholar (4131)   Find an Academic Assistant (18)
Find an Article PDF (4631926)   Today's Articles (1039)   Subscriber (49891)
Citation(s) in RCA

Indexed Articles
Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
For: DuBois SG, Krailo MD, Lessnick SL, Smith R, Chen Z, Marina N, Grier HE, Stegmaier K. Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 2009;52:324-7. [PMID: 18989890 PMCID: PMC2791370 DOI: 10.1002/pbc.21822] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Number Cited by Other Article(s)
51
André N, Verschuur A, Rome A, Coze C, Gentet JC, Padovani L. Low dose cytarabine in patients with relapsed or refractory Ewing sarcoma. Pediatr Blood Cancer 2009;53:238. [PMID: 19441111 DOI: 10.1002/pbc.21940] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
52
Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K, Ludwig JA. Ewing’s Sarcoma: Standard and Experimental Treatment Options. Curr Treat Options Oncol 2009;10:126-40. [PMID: 19533369 DOI: 10.1007/s11864-009-0104-6] [Citation(s) in RCA: 101] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2009] [Accepted: 04/21/2009] [Indexed: 12/21/2022]
PrevPage 2 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA